PATENT CLAIM ANALYSIS

Application Number: 15941856
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "397000"]

Abstract:
The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.

Claim (Index 4):
The method of  claim 1 , wherein the eye drop formulation is applied to the cornea of an eye from 1 to 6 times per day.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.21429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10510835', '13342161', '10558111', '10558020', '10523015']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7789094602104966
- 35 USC 102 Novelty (BERT): 0.5200712173907537
- Combined Prediction Score: 0.7530256359285223
- Mean Citation Score: 243.64410200000003
- Max Citation Score: 259.66473
- Similarity Product: 142.17511063496946

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test